Pure CE develops profitable, robust, and scalable businesses and investment portfolios that capitalize on disruptive technologies in recycling, power, transport, buildings and infrastructure.


Pure CE focuses on novel drug development and clinical research aimed at treating diseases and medical conditions. From pre-emptive diabetes diagnosis to single-cell proteins.


Our deep historical experience in this space includes investments in hospitals, pharmaceuticals, medical products manufacturers, distributors and service providers.

Advanced Technology

Advanced technology & Data intelligence underpins all business.

From SIRI to self-driving cars, artificial intelligence (AI) is progressing rapidly.

The application of methods for developing trading strategies based on AI, both in short-term time frames and for longer-term investing, is gaining popularity and there are a few hedge funds that are very active in this field.

Pure CE technology is about processing information, developing and validating models in real-time for optimal performance.